Browsing Tag

drug discovery platform

Transition Bio, Inc., a microfluidics-driven drug discovery platform company using biophysical sciences and artificial intelligence tools to map and…

Investment

Domainex Invests in the Creoptix WAVEdelta to Strengthen Its Fragment-Based Drug Discovery Platform

AIT News Desk Jan 12, 2021

Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to announce that it has invested in the WAVEdelta instrument from …

Technology

South Korean Company, Yuhan Pharmaceuticals Partners with Cyclica to Advance R&D Across Two…

AIT News Desk Nov 9, 2019

Renowned South Korean healthcare company, Yuhan Pharmaceuticals (Yuhan) and Cyclica Inc. (Cyclica), a leading neo biotechnology company announce a…

Technology

Exscientia Hires Director of Data Engineering to Scale up its AI Drug Discovery Platform

AIT News Desk Feb 15, 2019

Following a highly successful year and several drug discovery milestones using its flagship AI platform, Exscientia is pleased to welcome Andrew…

Machine Learning

Engine Biosciences Raises $10 Million in Seed Financing to Accelerate Drug Discovery Using Genomics…

Sudipto Ghosh Feb 1, 2018

San Francisco- and Singapore-based Biotech Company Raises $10 Million in Seed Round from Leading American and Asian Investors Engine…

drug discovery platform

Transition Bio Closes $50 Million Series A Financing to Accelerate Biomolecular Condensate Drug…

Domainex Invests in the Creoptix WAVEdelta to Strengthen Its Fragment-Based Drug Discovery Platform

South Korean Company, Yuhan Pharmaceuticals Partners with Cyclica to Advance R&D Across Two…

Exscientia Hires Director of Data Engineering to Scale up its AI Drug Discovery Platform

Engine Biosciences Raises $10 Million in Seed Financing to Accelerate Drug Discovery Using Genomics…